We are live on ! Find out more
GMED icon

Globus Medical

449 hedge funds and large institutions have $7.74B invested in Globus Medical in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 147 increasing their positions, 176 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $3.38M

2% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 52

0% more capital invested

Capital invested by funds: $7.72B → $7.74B (+$15.6M)

0% less funds holding

Funds holding: 450449 (-1)

4.38% less ownership

Funds ownership: 100.09%95.72% (-4.4%)

16% less repeat investments, than reductions

Existing positions increased: 147 | Existing positions reduced: 176

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

Holders
449
Holders Change
-1
Holders Change %
-0.22%
% of All Funds
6.45%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.26%
New
53
Increased
147
Reduced
176
Closed
52
Calls
$13.5M
Puts
$3.38M
Net Calls
+$10.2M
Net Calls Change
-$2.8M
Name Holding Trade Value Shares
Change
Change in
Stake
RIL
251
Rothschild Investment LLC
Illinois
$697K
MC
252
Montag & Caldwell
Georgia
$652K -$724K -10,260 -53%
Jane Street
253
Jane Street
New York
$648K -$8.76M -124,143 -93%
PNC Financial Services Group
254
PNC Financial Services Group
Pennsylvania
$637K +$1.98K +28 +0.3%
SAM
255
Securian Asset Management
Minnesota
$628K -$13.9K -197 -2%
CL
256
Choreo LLC
Illinois
$603K +$67.6K +957 +13%
RC
257
Roundview Capital
New Jersey
$560K +$7.27K +103 +1%
CGH
258
Crossmark Global Holdings
Texas
$554K +$30.8K +436 +6%
AI
259
Atria Investments
North Carolina
$550K -$23.8K -337 -4%
Fifth Third Bancorp
260
Fifth Third Bancorp
Ohio
$541K +$11.1K +157 +2%
A
261
AlphaQuest
New York
$523K +$516K +7,311 New
Cetera Investment Advisers
262
Cetera Investment Advisers
Illinois
$519K +$172K +2,431 +50%
LCM
263
Landscape Capital Management
New Jersey
$519K -$189K -2,678 -27%
NAS
264
Nicolet Advisory Services
Wisconsin
$505K +$30.7K +435 +6%
Commonwealth Equity Services
265
Commonwealth Equity Services
Massachusetts
$498K +$8.61K +122 +2%
M&T Bank
266
M&T Bank
New York
$496K +$17K +241 +4%
Envestnet Portfolio Solutions
267
Envestnet Portfolio Solutions
Illinois
$481K -$21K -297 -4%
CCA
268
Conservest Capital Advisors
Pennsylvania
$467K
Creative Planning
269
Creative Planning
Kansas
$463K +$22.2K +314 +5%
YMRC
270
Yorktown Management & Research Company
Virginia
$458K
MSRPS
271
Maryland State Retirement & Pension System
Maryland
$457K -$182K -2,577 -29%
BHCM
272
Brevan Howard Capital Management
Jersey
$447K -$42.6K -604 -9%
CCM
273
Coldstream Capital Management
Washington
$447K +$9.25K +131 +2%
SCM
274
Sterling Capital Management
North Carolina
$440K +$434K +6,144 New
RFC
275
Regions Financial Corp
Alabama
$429K +$1.91K +27 +0.5%

GMED Hedge Fund Activity: Q3 2024 in Review

449 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2024, worth a combined $7.74B — up 0.2% from $7.72B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GMED positions and 52 closed out — a net gain of 1 holder — while 147 added to existing stakes and 176 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $56.9M. The largest seller was Vestal Point Capital, exiting entirely with an estimated $61.6M sold.

  • 449 institutional investors held Globus Medical (GMED) as of Q3 2024, down from 450 in Q2 2024.
  • Funds reported $7.74B of Globus Medical stock for Q3 2024, up 0.2% quarter-over-quarter.
  • 53 funds opened new Globus Medical positions in Q3 2024 and 52 closed out, a net change of +1 holder.
  • The largest Globus Medical buyer in Q3 2024 was Citadel Advisors, an estimated $56.9M added.
  • The largest Globus Medical seller in Q3 2024 was Vestal Point Capital, an estimated $61.6M sold.

Based on aggregated 13F filings for Q3 2024.